相关实验视频

Updated: Jul 17, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

外体 miR-222-3p 通过激活 mTOR 信号传递,有助于割抗性前列腺癌

Weixi Wang¹, Piaoping Kong¹, Kangle Feng¹

¹Department of Laboratory Medicine, Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.

|September 6, 2023

概括

雌激素独立前列腺癌细胞释放含有miR-222-3p的外体,促进雌激素依赖前列腺癌的进展. 向这些外体miRNAs为割抵抗性前列腺癌提供了潜在的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

抗雄激素剥夺疗法 (ADT) 是晚期前列腺癌的基石,但抗药性不可避免地发展.
从雌激素依赖性前列腺癌 (ADPC) 过渡到致命的雌激素独立性前列腺癌 (AIPC) 或割抵抗性前列腺癌 (CRPC),仍然是一个重大的临床挑战.
外体微RNA (miRNA) 越来越被认为是细胞间通信的关键媒介,但它们在CRPC进展中的特定作用尚未完全理解.

研究的目的:

研究外体miRNAs在前列腺癌从ADPC向CRPC进展中的作用和机制.
确定特定的miRNAs参与调解过渡到一个更具侵略性,耐割的表型.
探索在CRPC中准外体miRNA的治疗潜力.

主要方法:

在AIPC和ADPC细胞中对miR-222-3p表达的定量分析.
在体外和体内实验中评估AIPC衍生的外体对ADPC细胞行为的影响 (增殖,迁移,入侵).
涉及miRNA测序,西部抹杀和途径分析 (例如mTOR信号) 的机制研究,以阐明外体miR-222-3p.p.影响的分子标和途径.

主要成果:

在AIPC细胞中发现miR-222-3p显著升高.
由AIPC细胞释放的外体携带miR-222-3p,在ADPC细胞吸收后,增强了它们的增殖,迁移和入侵.
外体转移miR-222-3p促进了ADPC细胞转化为AIPC类细胞,部分原因是通过MIDN向激活mTOR信号.
这种对膜机制突出显示了CRPC进展的新途径.

结论:

通过分泌含有miR-222-3p的外体细胞,AIPC细胞积极促进CRPC的进展.
外体miR-222-3p作为细胞功能重塑的关键驱动因素,促进过渡到割抵抗.
向外体miRNAs,包括miR-222-3p,为CRPC提供了一个有希望的治疗途径,可能与现有治疗结合使用.

关键词:

不依赖于雄激素的独立.在外基因组中,外基因组是外基因组.在mTOROR中使用mTOR.这是一个小RNARNA.前列腺癌是前列腺癌.

更多相关视频

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...